About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: Some Publications were unable to be listed below - please see that listing here. All other publications based on PubMedIDs are listed below.

 

Found 13 results
Filters: Keyword is Immunosuppressive Agents  [Clear All Filters]
2015
N. Khera, Majhail, N. S., Brazauskas, R., Wang, Z., He, N., Aljurf, M. D., Akpek, G., Atsuta, Y., Beattie, S., Bredeson, C. N., Burns, L. J., Dalal, J. D., Freytes, C. O., Gupta, V., Inamoto, Y., Lazarus, H. M., LeMaistre, C. F., Steinberg, A., Szwajcer, D., Wingard, J. R., Wirk, B., Wood, W. A., Joffe, S., Hahn, T. E., Loberiza, F. R., Anasetti, C., Horowitz, M. M., and Lee, S. J., Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial., Biol Blood Marrow Transplant, vol. 21, no. 10, pp. 1815-22, 2015.
P. Anderlini, Wu, J., Gersten, I., Ewell, M., Tolar, J., Antin, J. H., Adams, R., Arai, S., Eames, G., Horwitz, M. E., McCarty, J., Nakamura, R., Pulsipher, M. A., Rowley, S., Leifer, E., Carter, S. L., DiFronzo, N. L., Horowitz, M. M., Confer, D., H Deeg, J., and Eapen, M., Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study., Lancet Haematol, vol. 2, no. 9, pp. e367-75, 2015.
S. M. Devine, Owzar, K., Blum, W., Mulkey, F., Stone, R. M., Hsu, J. W., Champlin, R. E., Bin Chen, Y. -, Vij, R., Slack, J., Soiffer, R. J., Larson, R. A., Shea, T. C., Hars, V., Sibley, A. B., Giralt, S., Carter, S., Horowitz, M. M., Linker, C., and Alyea, E. P., Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncolo, J Clin Oncol, vol. 33, no. 35, pp. 4167-75, 2015.